Latest news
CervoMed Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Fri, 07 Aug 2026 22:01:42 GMTCervoMed Inc (CRVO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 19:42:02 GMTCervoMed Inc. (CRVO) Edges Lower to $2.77 as Shares Consolidate Within Tight Trading Range - Sign of Weakness - dars.gov.etdars.gov.et · Wed, 05 Aug 2026 19:38:38 GMTCervoMed Inc. (CRVO) Edges Lower to $2.77 as Shares Consolidate Within Tight Trading Range - Fibonacci Extension - dars.gov.etdars.gov.et · Wed, 05 Aug 2026 19:32:22 GMTCervoMed to Share Drug Program Progress at Aug. 11 Chat - Stock TitanStock Titan · Wed, 05 Aug 2026 11:30:00 GMTCervoMed to Participate in Fireside Chat to Highlight - GlobeNewswireGlobeNewswire · Wed, 05 Aug 2026 11:30:00 GMTCervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB) - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 09:15:00 GMTCervoMed says UK grants ILAP Innovation Passport for neflamapimod in Lewy body dementia - BitgetBitget · Tue, 04 Aug 2026 07:00:00 GMT